Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Viracta Therap
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
1
2
3
4
5
6
7
8
9
10
HQK 1001
/ Viracta Therap
nanatinostat
(VRx-3996) / Viracta Therap
arginine butyrate
(HQK-1004) / Boston University, Viracta Therap
vecabrutinib
(SNS-062) / Viracta Therap
